Season 2 (2021-2030)

Immunology - Recombinant Protein (1)

Modality Indication Targets Stage Company Project No. Detail
1 Candidate Selection of IL-2v-SAFA for the treatment of rare autoimmune disease
Recombinant Protein Systemic Lupus Erythematosus, IBD IL-2 Candidate AprilBio RS-2022-00165592
BACK